Biofortification Market Size

Increasing demand for high-nutrition food is driving the market growth

The market CAGR for biofortification is being propelled by reasons such as rising demand for high-nutrition foods and increased consumer health consciousness as a result of health issues such as nutritional deficiencies and malnutrition. According to Forbes, the world's population is predicted to reach 9.7 million people, necessitating a 70% increase in global food production over the following 30 years in order to feed everyone. The worldwide biofortification market is benefiting from technical advancements as well as increased agricultural expansion investments.

The need for biofortification is expected to expand in response to rising rates of nutritional deficiencies and the number of malnourished children. The Biofortification Market is expected to grow over the forecast period due to rising demand.

However, a lack of understanding about the benefits of biofortified crops is projected to hamper the biofortification market's growth. Numerous constraints on the production of genetically modified crops have the potential to stifle the expansion of the biofortification business. Biofortification requires trait variety in the primary, secondary, or tertiary gene pools of the chosen crop, which limits diversity.

For instance, the World Health Organization, this technology has the potential to help approximately 2 billion people suffering from iron deficiency-induced anemia. Furthermore, micronutrient deficiencies such as vitamin A, iron, and zinc impact more than half of the world's population. As a result, unlike traditional fortification, bio-fortification can reach the rural masses who live below the poverty line. Furthermore, studies show that this method is affordable to even the poorest members of society without sacrificing agronomic productivity. Thus, driving the biofortification market revenue.

Climate change poses significant challenges to global agriculture, affecting crop yields and food security. The Global Biofortification Market Industry is responding to these challenges by developing biofortified crops that are more resilient to environmental stressors. For instance, biofortified varieties of crops can be engineered to withstand drought or extreme temperatures, ensuring that they remain nutritious even in adverse conditions. This resilience is crucial for maintaining food supply chains and addressing the nutritional needs of populations in vulnerable regions. As climate change continues to impact agricultural productivity, the demand for biofortified crops is expected to rise, further driving market growth.

The Global Biofortification Market Industry is poised for substantial growth, with projections indicating a market value of 0.1 USD Billion in 2024 and a potential increase to 0.2 USD Billion by 2035. This growth is underpinned by a compound annual growth rate of 6.24% from 2025 to 2035. The increasing focus on nutrition, coupled with government support and consumer demand for biofortified foods, is likely to drive this upward trajectory. As stakeholders across the agricultural sector recognize the importance of biofortification in addressing global nutritional challenges, the market is expected to expand, offering opportunities for innovation and investment.

The Global Biofortification Market Industry is witnessing a surge in consumer awareness regarding the importance of nutrition. As more individuals become informed about the health benefits of biofortified foods, demand is likely to increase. This heightened awareness is driven by various factors, including educational campaigns and the growing prevalence of health-related issues linked to poor nutrition. Consumers are increasingly seeking out foods that offer enhanced nutritional profiles, which biofortified crops provide. This trend is expected to contribute to a compound annual growth rate of 6.24% from 2025 to 2035, as the market adapts to meet the evolving preferences of health-conscious consumers.

The Global Biofortification Market Industry is increasingly driven by the alarming rise in nutritional deficiencies worldwide. As populations grow and dietary patterns shift, deficiencies in essential vitamins and minerals such as iron, zinc, and vitamin A are becoming more prevalent. For instance, it is estimated that over 2 billion people globally suffer from micronutrient deficiencies. Biofortification offers a sustainable solution by enhancing the nutritional content of staple crops. This approach not only addresses health concerns but also contributes to food security. The market is projected to reach 0.1 USD Billion in 2024, reflecting the growing recognition of biofortified crops as a viable intervention.

Government initiatives play a crucial role in the expansion of the Global Biofortification Market Industry. Numerous countries are implementing policies and programs aimed at promoting biofortified crops to combat malnutrition. For example, several governments have established partnerships with agricultural research institutions to develop biofortified varieties of staple crops. These initiatives often include funding for research, education, and distribution of biofortified seeds to farmers. Such support not only enhances the visibility of biofortification but also encourages adoption among farmers and consumers. As a result, the market is expected to grow significantly, with projections indicating a potential increase to 0.2 USD Billion by 2035.

Technological advancements are transforming the Global Biofortification Market Industry by enabling more efficient and effective biofortification processes. Innovations in genetic engineering, molecular breeding, and biotechnology are facilitating the development of biofortified crops with enhanced nutritional profiles. These technologies allow for precise modifications to be made to the genetic makeup of crops, resulting in improved nutrient content without compromising yield. As these technologies become more accessible, farmers are likely to adopt biofortified varieties, leading to increased production and consumption. This trend is anticipated to contribute to the overall growth of the market, as stakeholders recognize the potential of technology to address nutritional deficiencies.

Leading market players are spending a lot of money on R&D to diversify their product offerings, which will spur further growth in the biofortification industry. Important market developments include new product releases, contractual agreements, mergers and acquisitions, greater investments, and collaboration with other organizations. Market participants are also engaging in a number of strategic actions to increase their global footprint. The biofortification industry must provide affordable products if it is to grow and thrive in an increasingly competitive and challenging market environment.

One of the most important business strategies employed by manufacturers in the global biofortification industry to assist customers and expand the market sector is local manufacturing to reduce operational costs. One of medicine's most important recent developments has come from the biofortification industry. Major players in the biofortification industry, such as DowDuPont (US), Syngenta (Switzerland), HarvestPlus (US), Bayer (Germany), BASE SE (Germany), Charles River, LemnaTec, Intertek and others, are trying to boost market demand by investing in research and development operations.

Syngenta AG, headquartered in Basel, Switzerland, is a provider of agricultural research and technology, including seeds and insecticides. ChemChina, a Chinese state-owned enterprise, owns it. Syngenta was formed in 2000 by the combination of Novartis and AstraZeneca's agrichemical operations, and was acquired by China National Chemical Corporation (ChemChina) in 2017. Syngenta Crop Protection, Syngenta Seeds, Adama, and Syngenta Group China are its business units. The Syngenta Group was founded in 2020, combining Syngenta, Adama, and Sinochem's agriculture sector into a single firm. Pesticides, selective herbicides, non-selective herbicides, fungicides, insecticides, and corn, soya, and biofuel are among Syngenta's main goods.

In September 2022, Syngenta Seedcare and Bioceres Crop Solutions collaborate to bring innovative biological sed treatments to market. Customers seeking cutting-edge biclogical seed treatment solutions will benefit (rom a global commercial and R&D collaboration announced between Syngenta Seedcare business aid Bioceres Crop.

The Monsanto Company was an American agrochemical and agricultural biotechnology firm headquartered in Creve Coeur, Missouri, founded in 1901. Roundup, a glyphosate-based herbicide created by Monsanto in the 1970s, is the company's most well-known product. Later, the company expanded into a significant producer of genetically modified crops. In 2018, the company was placed 199th on the Fortune 500 list of the top corporations in the United States by revenue. In 1983, Monsanto was one of four companies to insert genes into plants, and in 1987, it was one of the first to conduct field trials with genetically modified crops.

It was one of the top ten US chemical firms until it liquidated most of its chemical assets between 1997 and 2002 through a series of acquisitions and spin-offs that shifted the company's focus to biotechnology. In March 2018, Monsanto Company and Pairwise Plants established a collaboration to advance agricultural research and development by utilising gene-editing technologies. This would aid farmers in producing greater harvests and the company's product development.